Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections
作者： Warren Lowman , Gunter Schleicher
DOI: 10.1016/J.DIAGMICROBIO.2014.09.023
关键词: Intensive care medicine 、 Critically ill 、 Medicine 、 Odds ratio 、 Intensive care unit 、 Improved survival 、 Health evaluation 、 Carbapenemase-Producing Enterobacteriaceae 、 Antimicrobial 、 Carbapenem
摘要: We report on the clinical characteristics, antimicrobial therapy, and outcomes of 20 critically ill patients with severe OXA-48like infections. Carbapenem-based therapy demonstrated improved survival (odds ratio = 5.0) as compared non-carbapenem therapy. Risk factors for mortality included Acute Physiology Chronic Health Evaluation III score length stay, highlighting significant influence comorbidities severity underlying illness outcomes.
elsevier.com
dgmc.co.za 参考文章(12)
William A. Knaus, The APACHE III Prognostic System Chest. ,vol. 102, pp. 1920- ,(1992) , 10.1016/S0012-3692(16)40910-4
C. Navarro-San Francisco, M. Mora-Rillo, M.P. Romero-Gómez, F. Moreno-Ramos, A. Rico-Nieto, G. Ruiz-Carrascoso, R. Gómez-Gil, J.R. Arribas-López, J. Mingorance, J.R. Paño-Pardo, Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge Clinical Microbiology and Infection. ,vol. 19, ,(2013) , 10.1111/1469-0691.12091
Teresa C. Horan, Mary Andrus, Margaret A. Dudeck, CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control. ,vol. 36, pp. 309- 332 ,(2008) , 10.1016/J.AJIC.2008.03.002
Andrew F. Shorr, Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit* Critical Care Medicine. ,vol. 37, pp. 1463- 1469 ,(2009) , 10.1097/CCM.0B013E31819CED02
Jason A. Roberts, Jeffrey Lipman, Pharmacokinetic issues for antibiotics in the critically ill patient Critical Care Medicine. ,vol. 37, pp. 840- 851 ,(2009) , 10.1097/CCM.0B013E3181961BFF
Milena M McLaughlin, M Renee Advincula, Michael Malczynski, Grace Barajas, Chao Qi, Marc H Scheetz, Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes BMC Infectious Diseases. ,vol. 14, pp. 31- 31 ,(2014) , 10.1186/1471-2334-14-31
W. Lowman, M. Marais, K. Ahmed, L. Marcus, Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction Journal of Hospital Infection. ,vol. 88, pp. 66- 71 ,(2014) , 10.1016/J.JHIN.2014.06.009
Jean-Philippe Lavigne, Gaelle Cuzon, Christophe Combescure, Gisèle Bourg, Albert Sotto, Patrice Nordmann, Virulence of Klebsiella pneumoniae Isolates Harboring blaKPC-2 Carbapenemase Gene in a Caenorhabditis elegans Model PLoS ONE. ,vol. 8, pp. e67847- ,(2013) , 10.1371/JOURNAL.PONE.0067847
L. S. Tzouvelekis, A. Markogiannakis, M. Psichogiou, P. T. Tassios, G. L. Daikos, Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions Clinical Microbiology Reviews. ,vol. 25, pp. 682- 707 ,(2012) , 10.1128/CMR.05035-11
William A. Knaus, Douglas P. Wagner, Elizabeth A. Draper, Jack E. Zimmerman, Marilyn Bergner, Paulo G. Bastos, Carl A. Sirio, Donald J. Murphy, Ted Lotring, Anne Damiano, Frank E. Harrell, The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. ,vol. 100, pp. 1619- 1636 ,(1991) , 10.1378/CHEST.100.6.1619